SURG-08. COMBINED LOCAL TREATMENT OF BRAIN METASTASES: SURGERY AND POSTOPERATIVE STEREOTACTIC RADIOTHERAPY
نویسندگان
چکیده
Abstract INTRODUCTION Modern comprehensive local treatment of BM provides the possibility adequate control while maintaining a satisfactory quality life. METHODS Patients after metastasectomy and postoperative radiotherapy treated between 2007-2020 were evaluated. Local was assessed separately at site operated MM (localPFS) in other parts brain (distalPFS). RESULTS A total 118 patients enrolled (70 with WBRT), 54% women, median age 60 years, performance status Karnofsky 80%. The most common primary tumor lung carcinoma (39/118, 33%). Targeted stereotactic significantly more often indicated operations performed 2016 (p < 0.001). In period 2013-2019, gross resection achieved (83 vs 64%; p = 0.061). follow-up is 49 months. overall survival (OS) 9 months (6.2 - 12), localPFS 22 (14 unattainable), distPFS 11 (6.8 27 months), extracranialPFS (5.9 15). Stratification according to prognostic index brainmetgpa.com led significant separation for OS 0.00017). multivariate analysis, statistically positive factor compared WBRT (median 17 vs. 5.6 months, HR 0.59, 0.018) no effect on localPFS. CONCLUSION Our results are comparable presented by important foreign studies from prestigious oncology centers. We described targeted as an independent metastasectomy. study supported programme project Ministry Health Czech Republic reg. no. NV18-03-00398, NV19-03-00501 NV19-03-00559 Supported Health, Republic-conceptual development research organization (FNBr, 65269705).
منابع مشابه
Whole Brain Radiotherapy Combined with Stereotactic Radiosurgery versus Stereotactic Radiosurgery Alone for Brain Metastases.
BACKGROUND The aim of this study was to evaluate the effect of whole brain radiotherapy (WBRT) combined with streotactic radiosurgery versus stereotactic radiosurgery (SRS) alone for patients with brain metastases. MATERIALS AND METHODS This was a retrospective study that evaluated the results of 46 patients treated for brain metastases at Dr. Abdurrahman Yurtaslan Ankara Oncology Training an...
متن کاملHypofractionated stereotactic radiotherapy for the treatment of brain metastases.
BACKGROUND This retrospective review evaluated the efficacy and toxicity profiles of various dose fractionations using hypofractionated stereotactic radiotherapy (HSRT) in the treatment of brain metastases. METHODS Between 2004 and 2007, 36 patients with 66 brain metastases were treated with HSRT. Nine of these subjects were excluded because of the absence of post-treatment magnetic resonance...
متن کامل[Stereotactic radiosurgery and radiotherapy for brain metastases].
Brain metastases management is still controversial even though many trials are trying to define the respective roles of neurosurgery, whole-brain radiotherapy, single-dose stereotactic radiotherapy and fractionated stereotactic radiotherapy. In this article, we review data from trials that examine the role of radiosurgery and fractionated stereotactic radiotherapy in the management of brain met...
متن کاملStereotactic Radiotherapy for Liver Metastases
Liver metastases are common in oncologic patients, causing substantial morbidity and mortality. Systemic therapy is now standard palliative treatment for most patients with liver metastases, often providing transient responses and increased overall survival. In selected oligometastatic patients, local treatment can lead to long disease-free intervals and even permanent disease control. Although...
متن کاملStereotactic radiotherapy in epithelial ovarian cancer brain metastases patients
BACKGROUND In this report we present the results of the retrospective (survival and classification) analyses of possible prognostic factors prolonging survival in epithelial ovarian cancer brain metastases patients after stereotactic radiotherapy. We focus on a wide range of available predictors to establish survival in patients with a good health status and no more than three lesions. METHOD...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuro-oncology
سال: 2022
ISSN: ['1523-5866', '1522-8517']
DOI: https://doi.org/10.1093/neuonc/noac209.974